The most commonly reported side effects of sodium iodide i-123 include urticaria, pruritus, and rash, based on 52 FDA adverse event reports from 2008 to 2025. 11.5% of reports found the drug to be ineffective.
Percentages show how often each reaction appears relative to total reports for sodium iodide i-123.
These are voluntary reports and do not establish that sodium iodide i-123 caused these reactions.
Report severity
Seriousness is determined by the reporter, not by OpenClaim.
Other drugs that appear in adverse event reports alongside sodium iodide i-123. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
Taken alongside
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
57.7% of sodium iodide i-123 adverse event reports involve female patients and 17.3% involve male patients. The largest age group is adult at 61%. These figures reflect who reports side effects, not underlying risk.
Sex
Age group
Conditions and purposes for which patients were taking sodium iodide i-123 when the adverse event was reported.
Sodium Iodide I-123 is sold under the brand name Sodium Iodide I 123.
An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.